Company description

Evolva was founded in 2004 and has operations worldwide today. Based on a strong research foundation, Evolva is a pioneer and global leader in sustainable, fermentation based products, including resveratrol, stevia, nootkatone and valencene. Evolva’s Veri-te™ resveratrol is produced naturally from an innovative yeast fermentation process which delivers a consistent, contaminant-free, high-quality ingredient. Resveratrol’s role as a powerful healthy-aging ingredient is backed by almost 10,000 published scientific studies. These studies have shown that resveratrol can support many parts of the body that decline as we age, including our bones, brain, heart and skin. Veri-te™ resveratrol easily formulates into a variety of applications such as supplements, food, beverages, cosmetics, personal care products, pharmaceuticals and pet food.  For more information please click the Request More Information button or visit: www.veriteresveratrol.com

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Ingredient / Additive Manufacturer
Business segment focus Beauty; Bone and Joint health; Cardiovascular Health; Cognitive and mental function; Functional Beverages; Functional Food; Healthy Ageing; Pet Food / Animal Nutrition
Affiliated categories: Antioxidant |R&D |Sports Nutrition More

Recently at

27 nov 2018

Hi Europe 2018

27 - 29 November 2018 Frankfurt, Germany We were at stand 8M89 See our Exhibitor Profile   See full Exhibitor List

News about Evolva

How resveratrol rejuvenates blood vessels and supports healthy living

26 Aug 2019

How resveratrol rejuvenates blood vessels and supports healthy living

Thanks to many researchers and clinicians worldwide, resveratrol continues to shine in the spotlight with new positive findings collected in preclinical and clinical studies every day.

Read more

23 Aug 2019

Resveratrol strengthens the immune system through a combined approach

Scientists from the University of Buffalo investigated resveratrol and how this polyphenol helps combat depression and anxiety. The underlying mechanism discovered in this preclinical trial is described as resveratrol’s ability to inhibit the enzyme phosphodiesterase, which controls the cellular signaling molecule cAMP.

Read more

10 Jul 2019

Significant findings of new long-term study of Resveratrol in Post-Menopausal Women

Evolva (SIX: EVE) is pleased to announce that Emeritus Professor Peter Howe from the University of Newcastle, Australia will present outcomes from the recently concluded RESHAW study (Resveratrol Supporting Healthy Aging in Women) at the second Healthy Aging APAC summit, held July 9th-11th at the Hilton Singapore.

Read more

24 May 2019

Evolva's Veri-te™ resveratrol supports award winning innovation

Evolva is proud to announce that two Veri-te™ resveratrol partners are winner of the prestigious Nutraingredients Awards in two categories.

Read more

Contact information




View all contact information